https://www.selleckchem.com/products/msa-2.html
Introduction Aortic valve disease is the most common valvular heart disease. Aortic valve replacement (AVR) is the treatment of choice for aortic valve stenosis (AS). Multiple options have been developed to treat AS, corresponding to the steadily growing AVR case volume. The increased adoption of minimally invasive aortic valve replacement (mini-AVR) techniques, despite being technically challenging, is reflected in its advantageous outcomes. Continuous device development can add a critical value to the technical expertise and advance the
Like
Comment
Share
